#164: EMSP 2026. Progress, Hope and Real Challenges in Multiple Sclerosis
EMSP 2026 in Berlin highlighted how much is evolving in multiple sclerosis – from new diagnostic criteria and emerging therapies to long-overdue topics like fatigue and PIRA. At the same time, access to care across Europe remains a major challenge. In this article, I share my personal insights and key takeaways from the conference.
133: ECTRIMS 2025: First Highlights for MS Patients
ECTRIMS 2025 in Barcelona brings new insights into MS research. From biomarkers of progression to diet, menopause, and treatment, here’s what patients need to know.
